(Alliance News) - Stocks were called to open higher on Tuesday, following claims that trade talks between US President Donald Trump and Chinese President Xi Jinping are imminent. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and not separately reported by Alliance News: Read More
(Alliance News) - Stock prices in London opened mixed on Monday, ahead of the UK's manufacturing PMI reading and following the government's announced commitments to defence spending. Read More
(Alliance News) - GSK PLC on Monday announced the US Food & Drug Administration has accepted for review the new drug application for its liver disease treatment, linerixibat. Read More
(Alliance News) - The FTSE 100 outperformed in a mixed day for European equities, after the US Court of Appeals temporarily reinstated Donald Trump's tariffs. Read More
(Alliance News) - GSK PLC on Wednesday said it will stop a late-stage trial early for an investigational oral antibiotic to treat complicated urinary tract infections, or cUTIs, after the treatment showed positive results in an interim analysis. Read More
(Alliance News) - Stock prices in London closed in the red on Friday, following US President Donald Trump's renewed tariff threats against the EU and Apple. Read More
(Alliance News) - GSK PLC on Friday said its drug Blenrep has received a "positive opinion" from the European Medicines Agency's Committee for Medicinal Products for Human Use. Read More
(Alliance News) - European stocks opened higher on Friday, as a cooling of US yields calmed some investor nerves, while improved UK data boosted sterling. Read More
(Alliance News) - GSK PLC on Thursday said the US Food & Drug Administration has approved its asthma drug Nucala as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease, or COPD, who have an eosinophilic phenotype. Read More
(Alliance News) - GSK PLC on Monday said it has received approval in Japan for Blenrep combinations in the treatment of adults with relapsed or refractory multiple myeloma. Read More
(Alliance News) - The FTSE 100 pushed higher on Friday, ending the week on a strong note, and now at the level it roughly stood at prior to US President Donald Trump's 'liberation day' tariff melee. Read More
(Alliance News) - London's FTSE 100 outperformed European peers, though a share price fall for oil majors and a host of other shares that went ex-dividend kept a lid on the blue-chip index's progress. Read More
(Alliance News) - GSK announced on Wednesday that it has agreed with Boston Pharmaceuticals to buy steatotic liver disease medication efimosfermin alfa. Read More
(Alliance News) - London's FTSE was called down on Wednesday following criticisms from China on the US-UK trade deal being detrimental to third-party interests, and new threats from Europe for sanctions on Russia if a ceasefire in Ukraine is not reached. Read More
(Alliance News) - GSK PLC on Thursday gave an update on its investigational targeted inhibitor linerixibat as a treatment for relentless itch. Read More
